Luxembourg Institute of Health

Welcome to the LIH Newsletter. This edition covers the €60,000 grant awarded by Think Pink Luxembourg to support cancer immunotherapy research, Dr. Torsten Bohn's recognition in Clarivate’s Highly Cited Researchers report, and the launch of the 'Braincoach' app aimed at preventing dementia. We also cover the #CoVaLux conference on #COVID19 and pandemic preparedness, as well as LIH’s participation in the Researchers' Days with engaging interactive stands on cancer, food allergies, and epidemiology. Enjoy the read 💙 🔬

We are #hiring ! The Nutrition & Health Research Group led by Dr.Torsten Bohn within the Department of Precision Health at #LIH is looking for a #PostDoctoral researcher in #Nutrition. If you hold a #PhD in #Nutrition/ #PharmacyBiochemistry or comparable, and have experience in #ClinicalStudy set-up, don't hesitate to check the job offer! More information available here 👉 : https://lnkd.in/eUv9RHUi

Say hello to Non-Invasive Screening: New AI Tool Identifies Diabetes Using Voice Analysis 🗣️ #Diabetes (T2D) affects millions, with over 400 million cases undiagnosed globally. Early detection is critical, yet current tests remain costly and inaccessible for many. A team of researchers led by Abir Elbéji and Dr. Guy Fagherazzi from the Luxembourg Institute of Health’s Deep Digital Phenotyping Unit , has developed a revolutionary solution: AI-powered voice analysis. Their research, part of the Colive Voice program, shows that subtle changes in voice can accurately predict T2D risk—offering a non-invasive, affordable, and scalable screening method. This innovation has the potential to transform healthcare, making early diagnosis more accessible to underserved communities worldwide. 💡 Contribute to this breakthrough: Donate your voice now! Discover more: https://lnkd.in/dwgYQJaS

Celebrating Excellence in Research🔬✨ We are proud to announce that Dr. Shubhra Acharya, Ph.D. and Dr. Iria Fernández Botana have been honored with the Excellent Thesis Award during the University of Luxembourg’s PhD graduation ceremony on December 13th🎓 Dr. Shubhra Acharya conducted groundbreaking research on non-coding RNAs, uncovering their role as potential biomarkers for Parkinson’s disease. Dr. Iria Fernandez Botana advanced the understanding of immune dysfunction in Chronic Lymphocytic Leukemia, identifying new therapeutic strategies to restore T-cell function. We warmly congratulate them on this well-deserved recognition of their exceptional work! 👏

Big congratulations to Maryna Chepeleva, PhD student in the Multiomics Data Science group, Dept. of Cancer Research, for being named a top 3 AI Young Professional at the Women in AI (WAI) #BeneluxSummit2024! 🌟🎉 The summit is part of the prestigious WAI Awards program, celebrating 30 outstanding women across six categories—from AI research to entrepreneurship and diversity leadership. It’s all about empowering female innovators driving change in AI. Maryna shared her perspectives on AI challenges and the power of diverse voices, and now she’s off to the WAI Gala in February, where the winners will be announced. Wishing her the best of luck! 🍀 Learn more about WAI here: https://womeninai.nl/ Women in AI Benelux #AI #womeninAI

The Luxembourg Institute of Health (LIH) is thrilled to announce the appointment of Prof. Dr.Christof von Kalle as the new Director of the Luxembourg Center for Translational Research (LCTR) – Fuerschungsklinik Lëtzebuerg! With a remarkable career in translational oncology, gene therapy, and molecular medicine, Prof. Dr. von Kalle brings outstanding leadership and expertise to advance our mission. Welcome aboard!👏 🔗 Read the full news for more details 👇 https://lnkd.in/dBmxzKbD

📣 CANCER LECTURE SERIES ALERT! 📣  Join us for an insightful lecture with Prof. Lorenzo Galluzzi, exploring cutting-edge research on immunogenic cell death (ICD) and its pivotal role in activating adaptive immune responses. 👉 Discover how #radiation therapy (RT) functions as a potent ICD inducer, as shown in preclinical studies, from prophylactic vaccination models to abscopal effects. 👉 Dive into the mechanisms driving ICD, including the pivotal role of type I interferon (IFN) secretion by irradiated #cancer cells. 👉 Learn how mitochondrial outer membrane permeabilization (MOMP) drives this process and how it is regulated by mitophagy and caspases. 📅 December 20th, 2024 🕝 11am - 13pm 📍 CHL Centre, Amphitheatre room. 4, rue Ernest Barblé L-1210 Luxembourg 🔗 For full details click the link below: https://lnkd.in/dD6JChD9 Centre Hospitalier de Luxembourg #CancerResearch #Immunology #ICD #RadiationTherapy #TypeIIFN #Mitochondria #InnovativeTherapies

Congratulations to Dr. Rafael Luís! 🎉🎓 On December 2nd, Rafael successfully defended his PhD at the University of Luxembourg. His research focused on the Atypical Chemokine Receptor 2, conducted within the Department of Infection & Immunity at LIH, under the guidance of Andy Chevigné and Martyna Szpakowska. Rafael's PhD project, titled “Development of Selective Modulators to Investigate the Ligand Network and Therapeutic Potential of the Atypical Chemokine Receptor 2”, represents an important contribution to the field. We are especially proud to celebrate Rafael as the first doctoral candidate from the Luxembourg National Research Fund (FNR)-funded i2TRON DTU to complete the PhD journey. Well done! 👏

On November 15th, members of the Dept of Cancer Research of the LIH had the honor of attending the kick-off event for Télévie 2025! 🔬 This inspiring charity event, broadcast from RTL Luxembourg, brought together over 100 passionate volunteers, clinicians, sponsors, and researchers to officially launch the new fundraising period. As proud beneficiaries of #Télévie funding, we are deeply grateful for their ongoing support in the fight against #cancer. Let’s work together to make Télévie 2025 another incredible success!💙 Click the link below for more details: https://lnkd.in/d_bEwduB #cancer #cancerresearch #LIH

We are #hiring ! The National #Cytometry Platform (NCP) within the Integrated #BioBank of Luxembourg at #LIH and led by Dr. Antonio Cosma is looking for an Engineer Flow, Mass and Imaging Cytometry. 👨🔬 👩🔬 🧪 🔬 More information available here 👉 : https://lnkd.in/eKGDBpAa